0000000000141452

AUTHOR

Gaetano Cambula

showing 3 related works from this author

Post-acute COVID-19 neurological syndrome: A new medical challenge

2021

In December 2019, in Wuhan (China), a highly pathogenic coronavirus, named SARS-CoV-2, dramatically emerged. This new virus, which causes severe pneumonia, is rapidly spreading around the world, hence it provoked the COVID-19 pandemic. This emergency launched by SARS-CoV-2 also had, and still has, devastating socio-economic aspects. Assessing the impact of COVID-19 on vulnerable groups of people is crucial for the adaptation of governments’ responses. Growing scientific evidence suggests that it is essential to keep the attention on people after acute SARS-CoV-2 infection; indeed, some clinical manifestations are frequently present even after recovery. There is consensus on the need to defi…

medicine.medical_specialtyNeurologyCoronavirus disease 2019 (COVID-19)Brain damage COVID-19 Neurology Post-scute COVID-19 neurological syndrome SARS-CoV-2Brain damageReviewScientific evidence03 medical and health sciences0302 clinical medicinePandemicmedicine030212 general & internal medicineIntensive care medicineStrokebusiness.industrySARS-CoV-2neurologyRCOVID-19General Medicinebrain damagemedicine.diseasepost-scute COVID-19 neurological syndromeDeliriumMedicinemedicine.symptombusinessPneumonia (non-human)030217 neurology & neurosurgery
researchProduct

Post-acute COVID-19 neurological syndrome: a new medical 2 challenge

2021

In December 2019, inWuhan (China), a highly pathogenic coronavirus, named SARS-CoV-2, dramatically emerged. This new virus, which causes severe pneumonia, is rapidly spreading around the world, hence it provoked the COVID-19 pandemic. This emergency launched by SARS-CoV-2 also had, and still has, devastating socio-economic aspects. Assessing the impact of COVID-19 on vulnerable groups of people is crucial for the adaptation of governments' responses. Growing scientific evidence suggests that it is essential to keep the attention on people after acute SARSCoV- 2 infection; indeed, some clinical manifestations are frequently present even after recovery. There is consensus on the need to defin…

brain damage;SARS-CoV-2;COVID-19COVID-19 neurological syndromeneurology;
researchProduct

Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient

2021

In the recent pandemic disease, called COVID-19, the role of neurologists and neurobiologists represents a chance to study key features of brain infection and deepen neurological manifestations of COVID-19 and other coronavirus infections. In fact, many studies suggest brain damage during infection and persistent neurological symptoms after COVID-19 infection. Reverse transcription PCR test, antibody tests, Computed Tomography (CT) of the lung, and Magnetic Resonance (MR) of the brain of the patient were periodically performed during this case report for eight months after infection. The aim of this article is to describe the prolonged neurological clinical consequences related to COVID-19.…

Neurological signsPediatricsmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)neurological disordersCase ReportBrain damagelcsh:RC321-57103 medical and health sciences0302 clinical medicineNeurological syndromepost-COVID-19MedicineIn patient030212 general & internal medicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryLungmedicine.diagnostic_testbusiness.industrySARS-CoV-2General NeuroscienceCOVID-19Magnetic resonance imagingbrain damagemedicine.anatomical_structuremedicine.symptombusiness030217 neurology & neurosurgeryCoronavirus Infections
researchProduct